Cannabis (THC-Dominant)
Other ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Cannabis (THC-dominant) is not supported by NutriStack. Safety information only.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This safety record covers a controlled, investigational, or otherwise out-of-scope substance. It remains available for reference, but it is not part of NutriStack's public supplement publication set.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Cannabis (THC-Dominant) is an other. NutriStack rates the overall evidence as insufficient. This profile indexes 15 sources.
The bottom line
Evidence rating insufficient. 15 sources indexed (2007–2025), with 0 interaction records on file.
Dosing & protocol.
What it actually costs.
Real-world pricing across three quality tiers. Assumes Not recommended / non-supplement.
No effective supplement dose exists. Cost is intentionally not modeled for this regulated recreational substance. Updated 2026-05-28.
The same dose, as food.
How much you'd eat to match a supplemental dose.
THC-dominant cannabis is a psychoactive drug exposure, not a nutrient with a food-equivalent target.
Full safety detail.
Side effects
- Impaired judgment and reaction time
- Anxiety or panic
- Tachycardia
- Short-term memory impairment
- Cannabis hyperemesis in susceptible users
- Cannabis use disorder
- Psychosis risk in vulnerable individuals
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
15- 1Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis.PMIDStorck W et al. · Heart · 2025
Meta-analysis found positive associations between cannabis use and acute coronary syndrome, stroke, and cardiovascular death in real-world observational data.
- 2Evaluating Delta-8-THC-Induced Psychosis: A Systematic ReviewPMIDRalston MJ, Osman A · Clinical neuropharmacology · 2025
Ralston MJ, Osman A. Evaluating Delta-8-THC-Induced Psychosis: A Systematic Review. Clinical neuropharmacology. 2025
- 3High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic ReviewPMIDRittiphairoj T, Leslie L, Oberste JP et al. · Annals of internal medicine · 2025
Rittiphairoj T, Leslie L, Oberste JP et al.. High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review. Annals of internal medicine. 2025
- 4Interventions Addressing Cannabis Use During Pregnancy: A Systematic ReviewPMIDGroff D, Bollampally P, Buono F et al. · Journal of addiction medicine · 2023
Groff D, Bollampally P, Buono F et al.. Interventions Addressing Cannabis Use During Pregnancy: A Systematic Review. Journal of addiction medicine. 2023
- 5Roadside screening tests for cannabis use: A systematic reviewPMIDWennberg E, Windle SB, Filion KB et al. · Heliyon · 2023
Wennberg E, Windle SB, Filion KB et al.. Roadside screening tests for cannabis use: A systematic review. Heliyon. 2023
- 6Cannabis for the Treatment of Fibromyalgia: A Systematic ReviewPMIDStrand NH, Maloney J, Kraus M et al. · Biomedicines · 2023
Strand NH, Maloney J, Kraus M et al.. Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines. 2023
- 7Systematic review and rationale of using psychedelics in the treatment of cannabis use disorderPMIDPhan AN, Terry GE · Frontiers in psychiatry · 2023
Phan AN, Terry GE. Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder. Frontiers in psychiatry. 2023
- 8Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic ReviewPMIDSherpa ML, Shrestha N, Ojinna BT et al. · Cureus · 2022
Sherpa ML, Shrestha N, Ojinna BT et al.. Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review. Cureus. 2022
- 9A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management OptionsPMIDSenderovich H, Patel P, Jimenez Lopez B et al. · Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
Senderovich H, Patel P, Jimenez Lopez B et al.. A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2022
- 10A systematic review of the effects of cannabis on cognition in people with multiple sclerosisPMIDLandrigan J, Bessenyei K, Leitner D et al. · Multiple sclerosis and related disorders · 2022
Landrigan J, Bessenyei K, Leitner D et al.. A systematic review of the effects of cannabis on cognition in people with multiple sclerosis. Multiple sclerosis and related disorders. 2022
- 11Cannabis induced psychosis: A systematic review on the role of genetic polymorphismsPMIDCarvalho C, Vieira-Coelho MA · Pharmacological research · 2022
Carvalho C, Vieira-Coelho MA. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms. Pharmacological research. 2022
- 12Cardiovascular Effects of Medical Marijuana: A Systematic ReviewPMIDPasha AK, Clements CY, Reynolds CA et al. · The American journal of medicine · 2021
Pasha AK, Clements CY, Reynolds CA et al.. Cardiovascular Effects of Medical Marijuana: A Systematic Review. The American journal of medicine. 2021
- 13Cannabis and Male Fertility: A Systematic ReviewPMIDPayne KS, Mazur DJ, Hotaling JM et al. · The Journal of urology · 2019
Payne KS, Mazur DJ, Hotaling JM et al.. Cannabis and Male Fertility: A Systematic Review. The Journal of urology. 2019
- 14Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis.PMIDScott JC et al. · JAMA Psychiatry · 2018
Meta-analysis found a small overall association between frequent cannabis use and reduced cognitive performance, with weaker effects after more than 72 hours of abstinence.
- 15Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.PMIDMoore TH et al. · Lancet · 2007
Systematic review found cannabis use associated with increased psychotic outcomes, with stronger risk estimates in more frequent users.
Common questions.
Quick answers about Cannabis (THC-Dominant), drawn from the data on this page.
What is Cannabis (THC-Dominant)?
Cannabis (THC-dominant) is not supported by NutriStack. Safety information only.
What are the side effects of Cannabis (THC-Dominant)?
Reported side effects include impaired judgment and reaction time, anxiety or panic, tachycardia, short-term memory impairment, cannabis hyperemesis in susceptible users, cannabis use disorder. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Cannabis (THC-Dominant)?
NutriStack rates this as Insufficient, meaning the body of evidence reviewed in NutriStack's tiering framework. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Cannabis (THC-Dominant) in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.